- Pharmacovigilance disproportionality analysis detected EH-associated signals: dry mouth, insomnia and palpitations; sleep disorder flagged in primary analysis, constipation in sensitivity analysis.
- Network pharmacology implicated Neuroactive ligand-receptor interaction, Pathways of neurodegeneration and Dopaminergic synapse as key adverse-event related pathways.
- Molecular docking suggests ephedrine targets downstream signalling common to neurotransmitter systems, notably the dopaminergic system, differing from aconitine and spinosin.
Pharmaceuticals (Basel). 2026 Aug 24;19(9):1340. doi: 10.3390/ph19091340.
ABSTRACT
Background/Objectives: Ephedrae Herba (EH) is widely used in traditional East Asian medicine, but safety concerns regarding its adverse events remain. This study aimed to investigate EH-associated adverse events using clinical pharmacovigilance data and to perform exploratory in silico analyses to propose potential molecular mechanisms underlying these adverse events. Methods: A disproportionality analysis was performed using individual case safety reports from the Korea Adverse Event Reporting System database. EH-containing products were compared with other herbal medicine products using reporting odds ratios (RORs), proportional reporting ratios, and information components. Network pharmacology identified adverse event-related genes and pathways, and protein-protein interaction networks were constructed. Molecular docking predicted direct adverse event-associated targets of ephedrine and compared mechanisms with control compounds (aconitine and spinosin). Results: Four adverse-event signals were detected in the primary analysis: sleep disorder, dry mouth, insomnia, and palpitations. Sensitivity analysis identified four signals, with three (dry mouth, insomnia, and palpitations) consistent across both analyses; constipation emerged only in the sensitivity analysis. Conclusions: Adverse event-associated network analysis predicted key pathways: Neuroactive ligand-receptor interaction, Pathways of neurodegeneration, and Dopaminergic synapse. Molecular docking predicted that ephedrine may act on downstream signaling mechanisms shared by neurotransmitter systems, including the dopaminergic system, distinct from control compounds.
PMID:42797385 | DOI:10.3390/ph19091340
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

